Enavate Sciences GP, LLC — 13F Holdings & Portfolio
CIK 1953107 · latest 13F-HR filed 2026-08-14
Enavate Sciences GP, LLC manages $345.4M in 13F-reported U.S. long-equity assets across 7 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SION (31.56%), ZBIO (28.80%), IMNM (22.17%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions and exited 0; 2 existing positions rose in reported value and 4 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- ZENAS BIOPHARMA INC$22.8M +29.8%
- SIONNA THERAPEUTICS INC$9.7M +9.7%
Top Trims
- COMPASS THERAPEUTICS INC-$24.1M -58.6%
- UPSTREAM BIO INC-$5.1M -23.1%
- BRIDGEBIO ONCOLOGY THERAPEUT-$3.5M -14.9%
- CAMP4 THERAPEUTICS CORP-$3.4M -35.5%
Enavate Sciences GP, LLC Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | SIONNA THERAPEUTICS INC | SION | 829401108 | $109.0M | 31.56% | 2,478,030 | SH |
| 2 | ZENAS BIOPHARMA INC | ZBIO | 98937L105 | $99.5M | 28.80% | 3,919,159 | SH |
| 3 | IMMUNOME INC | IMNM | 45257U108 | $76.6M | 22.17% | 3,613,799 | SH |
| 4 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 107924102 | $20.0M | 5.80% | 2,626,946 | SH |
| 5 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $17.1M | 4.94% | 7,788,150 | SH |
| 6 | UPSTREAM BIO INC | UPB | 91678A107 | $17.0M | 4.93% | 2,459,703 | SH |
| 7 | CAMP4 THERAPEUTICS CORP | CAMP | 13463J101 | $6.2M | 1.80% | 1,425,541 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $345.4M | 7 | 0001953107-26-000012 |
| 2026-03-31 | 2026-05-15 | $351.5M | 7 | 0001953107-26-000008 |
| 2025-12-31 | 2026-02-17 | $506.8M | 7 | 0001953107-26-000003 |
| 2025-09-30 | 2025-11-14 | $327.5M | 7 | 0001953107-25-000014 |
FLOOR 8
NEW YORK, NY 10019